2024年5月8日 · Velcade (bortezomib) is used to treat multiple myeloma (MM) and mantle cell lymphoma (MCL) in adults. Velcade injection is a proteasome inhibitor, a type of targeted …

Velcade® (bortezomib) is an anti-cancer agent available for injection into a vein or under skin. Velcade is FDA approved for multiple myeloma treatment.

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. [4] This includes multiple myeloma in …

2021年12月17日 · Velcade is a brand-name prescription medication. It’s FDA-approved to treat two forms of blood cancer in adults: multiple myeloma and mantle cell lymphoma (MCL). With …

2024年10月6日 · Overview: Bortezomib (Velcade, Boruzu) is used to treat certain blood cancers, including multiple myeloma and mantle cell lymphoma. It works by preventing cancer cells …

BORTEZOMIB (bor TEZ oh mib) treats lymphoma. It may also be used to treat multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow …

VELCADE (1.3 mg/m 2) is administered intravenously in combination with intravenous rituximab, cyclophosphamide, doxorubicin and oral prednisone (VcR-CAP) for 6, three week treatment …

2022年12月20日 · Velcade (bortezomib) is an antineoplastic (anticancer) agent used to treat multiple myeloma and mantle cell lymphoma, and is sometimes given after other cancer …

2025年2月12日 · Velcade is a prescription drug used to treat multiple myeloma and mantle cell lymphoma. Learn about the drug’s dosages, form, strength, and more.

2024年12月13日 · Velcade (bortezomib) is a brand-name injection prescribed for multiple myeloma and mantle cell lymphoma. As with other drugs, Velcade can cause side effects, …